Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Isosorbide mononitrate manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Israel

Clear all

1 products found

isosorbide mononitrate

Tablets, modified release (MR) 30mg, 60mg, 120mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Israel
GMP approvals
FDA, EU GMP
Unavailable markets
United States
Manufacturer #620
It is focused on the development of novel and proprietary formulations of existing molecules and high-complexity generic formulations. It was founded in the late 1960s. They have a diverse portfolio of more than 85 branded and generic products in more than 175 dosage forms. They have a wide network of more than 30 countries worldwide.

Manufacturer usually replies in 9 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Isosorbide mononitrate Manufacturers

Markets of interest

As organic nitrate with vasodilating properties, Isosorbide mononitrate is prescribed to prevent angina attacks. The substance works by relaxing the smooth muscles of both arteries and veins, but predominantly veins to reduce cardiac preload. The drug has a longer duration of action than nitroglycerin due to its slow onset of absorption and metabolism. The substance is available for sale in the form of tablets, tablets, modified release (mr), tablets, prolonged-release, tablets, extended-release (er), capsules, extended-release (er), from manufacturers in various countries including Y. The drug is provided by a wide range of Isosorbide mononitrate suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Isosorbide mononitrate manufacturers and distributors are based in China and North Korea.

Licensing and brand names

Isosorbide mononitrate was first approved by the FDA for use in the United States in 1991. Under the trade name Elantan, the medication was approved by the EMA in the European Union in 2011. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Imdur, Ismo, Ismn, Monoket. One of the most popular branded versions of Isosorbide mononitrate is manufactured and supplied by the Chinese pharmaceutical company Shandong Keyuan. Other manufacturing companies and distributors from European Union, Bosnia and Herzegovina, Canada, Ukraine, Israel have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Isosorbide mononitrate as an active ingredient.

Target supply price

The wholesale acquisition cost of or isosorbide mononitrate oral tablet, extended-release 30 mg is around $19 for a supply of 30 tablets. The retail price of the 60mg prolonged-release tablets of the substance in Europe reaches 9 EUR per pack. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Isosorbide mononitrate manufacturers and suppliers that you are looking for. You can also find the dossier status of Isosorbide mononitrate and the GMP approvals of the different variants of the medication. The product description of all Isosorbide mononitrate suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Isosorbide mononitrate is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation